C Fairfield, L Penninga, J Powell… - Cochrane Database …, 2018 - cochranelibrary.com
Background Liver transplantation is an established treatment option for end‐stage liver failure. Now that newer, more potent immunosuppressants have been developed …
G Sgourakis, G Dedemadi - World Journal of Gastroenterology …, 2014 - ncbi.nlm.nih.gov
Thirty-six randomized controlled trials and two meta-analyses were reviewed. With respect to adult patients undergoing first orthotopic liver transplantation (OLT), steroid replacement …
J Lerut, E Bonaccorsi‐Riani, P Finet… - Transplant …, 2009 - Wiley Online Library
Because of the markedly improved short‐term results of liver transplantation (LT) and persistently high number of long‐term complications, the attention of transplant physicians …
CB Ramirez, C Doria, AM Frank… - Clinical …, 2013 - Wiley Online Library
Introduction Corticosteroids (CS) have been standard immunosuppression to prevent and treat rejection. However, CS are associated with increased risk of infection, obesity …
SJ Pelletier, K Vanderwall, MA Debroy… - Transplantation …, 2005 - Elsevier
Steroids are a mainstay in liver transplantation for induction and maintenance immunosuppression but are associated with significant adverse effects. While prior studies …
This work is a 1‐yr interim analysis of a prospective, randomized, multicenter trial evaluating the effect of corticosteroid‐free immunosuppression on hepatitis C virus–positive (HCV+) …
Background. Corticosteroids are commonly used in the immunosuppression therapy after liver transplantation, yet are associated with considerable side effects. Retrospective studies …
Steroid use after liver transplantation (LT) has been associated with diabetes, hypertension, hyperlipidemia, obesity, and hepatitis C (HCV) recurrence. We performed meta‐analysis …
This randomized, prospective, multicenter trial compared the safety and efficacy of steroid‐ free immunosuppression (IS) to the safety and efficacy of 2 standard IS regimens in patients …